Synthetic blood group antigens for anti-A removal device and their interaction with monoclonal anti-A IgM

Transplant Immunology

Volumn 16, Issue 3-4, 2006, Pages 245-249

  Solovan, Jennifer C ^a,b   Oh, Heung Il ^a,b   Alikhani, Azadeh ^a,b   Gautam, Shalini ^a,b   Vlasova, Katherine ^d   Korchagina, Elena Y ^e   Bovin, Nicolai V ^e   Federspiel, William J ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b University of Pittsburgh   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d Cantox Health Sciences International   (Canada)

^e SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

ABO incompatible transplantation; Atrisaccharide; Blood group antibodies; Hyperacute organ rejection; Therapeutic affinity separations

Indexed keywords

ATRISACCHARIDE ANTIGEN; BLOOD GROUP A ANTIBODY; BLOOD GROUP ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; POLYACRYLAMIDE; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BLOOD FILTRATION; BLOOD GROUP ABO INCOMPATIBILITY; CONJUGATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FILTER; MATHEMATICAL MODEL; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FILTRATION; GRAFT REJECTION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; MICE;

EID: 33751334143     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.08.003     Document Type: Article

References (20)

1. Platt J.L. Antibodies in graft rejection. In: Bach F.H., and Auchincloss H. (Eds). Transplant Immunology. 1st ed. (1995), Wiley-Liss 113-179
2. Alexandre G.P., De Bruyere M., Squifflet J.P., Moriau M., Latinne D., and Pirson Y. Human ABO-incompatible living donor renal homografts. Neth J Med 28 6 (1985) 231-234
3. Bannett A.D., McAlack R.F., Raja R., Baquero A., and Morris M. Experiences with known ABO-mismatched renal transplants. Transplant Proc 19 6 (1987) 4543-4546
4. Hanto D.W., Fecteau A.H., Alonso M.H., Valente J.F., and Whiting J.F. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transplant 9 1 (2003) 22-30
5. Toma H. ABO-incompatible renal transplantation. Urol Clin North Am 21 2 (1994) 299-310
6. Ishida H., Koyama I., Sawada T., Utsumi K., Murakami T., Sannomiya A., et al. Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantation. Transplantation 70 4 (2000) 681-685
7. Sonnenday C.J., Warren D.S., Cooper M., Samaniego M., Haas M., King K.E., et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 4 8 (2004) 1315-1322
8. Tanabe K., Takahashi K., Sonda K., Tokumoto T., Ishikawa N., Kawai T., et al. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation 65 2 (1998) 224-228
9. Tyden G., Kumlien G., Genberg H., Sandberg J., Lundgren T., and Fehrman I. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 5 1 (2005) 145-148
10. Bouget J., Chevret S., Chastang C., and Raphael J.C. Plasma exchange morbidity in Guillain-Barre syndrome: results from the French prospective, randomized, multicenter study. The French Cooperative Group. Crit Care Med 21 5 (1993) 651-658
11. Madore F. Plasmapheresis. Technical aspects and indications. Crit Care Clin 18 2 (2002) 375-392
12. Rydberg L., Bengtsson A., Samuelsson O., Nilsson K., and Breimer M.E. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transpl Int 17 11 (2005) 666-672
13. Hout M.S., LeJeune K.E., Schaack T.M., Bristow D.K., and Federspiel W.J. Specific removal of anti-A and anti-B antibodies by using modified dialysis filters. ASAIO J 46 6 (2000) 702-706
14. Hout M.S. Selective antibody removal from blood, plasma and buffer using hollow fiber-based specific antibody filters (2003), University of Pittsburgh, Pittsburgh
15. Bovin N.V. Polyacrylamide-based glycoconjugates as tools in glycobiology. Glycoconj J 15 5 (1998) 431-446
16. Korchagina E., and Bovina N.V. Synthesis of spaced trisaccharides with blood group A and B specificity, their fragments, and structural analogs. Bioorg Khim 18 2 (1992) 283-298
17. Bovin N.V., Korchagina E., Zemlyanukhina T.V., Byramova N.E., Galanina O.E., Zemlyakov A.E., et al. Synthesis of polymeric neoglycoconjugates based on N-substituted polyacrylamides. Glycoconj J 10 2 (1993) 142-151
18. Rieben R., Korchagina E.Y., Bovin N.V., and Daha M.R. Specificity of monoclonal antibodies against ABH and related structures tested by ELISA with synthetic glycoconjugates. Transfus Clin Biol 4 1 (1997) 47-54
19. Kaneko M., Kato Y., Horiuchi H., and Osawa M. Molecular characterization of a human monoclonal antibody to B antigen in ABO blood type. Immunol Lett 86 1 (2003) 45-51
20. Rieben R., Tucci A., Nydegger U.E., and Zubler R.H. Self tolerance to human A and B histo-blood group antigens exists at the B cell level and cannot be broken by potent polyclonal B cell activation in vitro. Eur J Immunol 22 10 (1992) 2713-2717